Suppr超能文献

以仔猪作为人类耳蜗药代动力学的代表性模型,使用耳蜗导管进行内耳给药的研究。

Investigation of inner ear drug delivery with a cochlear catheter in piglets as a representative model for human cochlear pharmacokinetics.

作者信息

Yildiz Erdem, Gadenstaetter Anselm J, Gerlitz Matthias, Landegger Lukas D, Liepins Rudolfs, Nieratschker Michael, Glueckert Rudolf, Staecker Hinrich, Honeder Clemens, Arnoldner Christoph

机构信息

Christian Doppler Laboratory for Inner Ear Research, Department of Otorhinolaryngology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

Department of Otorhinolaryngology, Head and Neck Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

出版信息

Front Pharmacol. 2023 Mar 9;14:1062379. doi: 10.3389/fphar.2023.1062379. eCollection 2023.

Abstract

Hearing impairment is the most common sensory disorder in humans, and yet hardly any medications are licensed for the treatment of inner ear pathologies. Intricate pharmacokinetic examinations to better understand drug distribution within this complex organ could facilitate the development of novel therapeutics. For such translational research projects, animal models are indispensable, but differences in inner ear dimensions and other anatomical features complicate the transfer of experimental results to the clinic. The gap between rodents and humans may be bridged using larger animal models such as non-human primates. However, their use is challenging and impeded by administrative, regulatory, and financial hurdles. Other large animal models with more human-like inner ear dimensions are scarce. In this study, we analyzed the inner ears of piglets as a potential representative model for the human inner ear and established a surgical approach for intracochlear drug application and subsequent apical sampling. Further, controlled intracochlear delivery of fluorescein isothiocyanate-dextran (FITC-d) was carried out after the insertion of a novel, clinically applicable CE-marked cochlear catheter through the round window membrane. Two, six, and 24 hours after a single injection with this device, the intracochlear FITC-d distribution was determined in sequential perilymph samples. The fluorometrically assessed concentrations two hours after injection were compared to the FITC-d content in control groups, which either had been injected with a simple needle puncture through the round window membrane or the cochlear catheter in combination with a stapes vent hole. Our findings demonstrate not only significantly increased apical FITC-d concentrations when using the cochlear catheter but also higher total concentrations in all perilymph samples. Additionally, the concentration decreased after six and 24 hours and showed a more homogenous distribution compared to shorter observation times.

摘要

听力障碍是人类最常见的感觉障碍,但几乎没有任何药物被批准用于治疗内耳疾病。进行复杂的药代动力学研究以更好地了解药物在这个复杂器官内的分布,可能会促进新型疗法的开发。对于此类转化研究项目,动物模型是必不可少的,但内耳尺寸和其他解剖特征的差异使实验结果向临床的转化变得复杂。啮齿动物和人类之间的差距可以通过使用更大的动物模型,如非人类灵长类动物来弥合。然而,它们的使用具有挑战性,受到行政、监管和资金障碍的阻碍。其他具有更类似人类内耳尺寸的大型动物模型很少。在本研究中,我们分析了仔猪的内耳作为人类内耳的潜在代表性模型,并建立了一种用于耳蜗内药物应用和随后顶端采样的手术方法。此外,在通过圆窗膜插入一种新型的、临床适用的带有CE标志的耳蜗导管后,进行了异硫氰酸荧光素-葡聚糖(FITC-d)的可控耳蜗内递送。在使用该装置单次注射后2、6和24小时,在连续的外淋巴样本中测定耳蜗内FITC-d的分布。将注射后两小时通过荧光测定评估的浓度与对照组的FITC-d含量进行比较,对照组要么通过圆窗膜简单针刺注射,要么通过带有镫骨通气孔的耳蜗导管注射。我们的研究结果不仅表明使用耳蜗导管时顶端FITC-d浓度显著增加,而且所有外淋巴样本中的总浓度也更高。此外,浓度在6和24小时后下降,与较短观察时间相比显示出更均匀的分布。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5461/10034346/2d26f3dbdc60/fphar-14-1062379-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验